聞泰科技(600745.SH):已接到AI PC項目並已實現量產
格隆匯4月15日丨聞泰科技(600745.SH)在投資者互動平台表示,作為全球領先的半導體和產品集成企業,公司在手機和筆電領域已積累了多年的生產製造經驗,公司進一步融合AI的應用場景,積極配合客户將人工智能向手機、平板、筆電、IoT、汽車電子等領域普及。AI PC方面,公司已接到AI PC項目並已實現量產;AI手機業務方面,公司已與海外客户對接AI Phone項目,正在正常推進中。新興領域的佈局和拓展可能存在後續市場環境、產業化落地、項目進度等方面的不確定因素,項目訂單可能根據客户自身戰略規劃及市場需求而聯動調整,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.